Evidence map›Paper›PMID 37970357›Full record

ArticleAmerican journal of cancer research2023

Inhibition of Na+/H+ exchanger (NHE) 7 by 5-(N-ethyl-N-isopropyl)-Amiloride displays anti-cancer activity in non-small cell lung cancer by disrupting cancer stem cell activity and downregulating PD-L1 expression.

Bing-Yen Wang, Huan-Ting Shen, Yu-Ling Lee, Peng-Ju Chien, Wen-Wei Chang

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Bing-Yen WangDivision of Thoracic Surgery, Department of Surgery, Changhua Christian Hospital No. 135, Nanhsiao Street, Changhua 500209, Taiwan.
Huan-Ting ShenDepartment of Pulmonary Medicine, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation No. 88, Sec. 1, Fengxing Rd., Tanzi Dist., Taichung 427, Taiwan.
Yu-Ling LeeDepartment of Biomedical Sciences, Chung Shan Medical University No. 110, Sec. 1, Jianguo N. Rd., Taichung 402306, Taiwan.
Peng-Ju ChienDepartment of Biomedical Sciences, Chung Shan Medical University No. 110, Sec. 1, Jianguo N. Rd., Taichung 402306, Taiwan.
Wen-Wei ChangDepartment of Biomedical Sciences, Chung Shan Medical University No. 110, Sec. 1, Jianguo N. Rd., Taichung 402306, Taiwan.
Chung Shan Medical University · TWChung Shan Medical University Hospital · TWNational Chung Hsing University · TWTaipei Tzu Chi Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The alkaline intracellular environment of cancer cells is critical for cell proliferation and controlled by various plasma membrane transporters including Na+/H+ exchangers (NHEs). NHEs can also mediate cell behavior by regulating signaling transduction. In this study, we investigated the role of NHE7 in cancer stem cell (CSC) activity in non-small cell lung cancer (NSCLC) cells and the potential therapeutic implications of targeting NHE7 and the associated immune checkpoint molecule PD-L1. By analyzing the database from The Cancer Genome Atlas, we found a positive correlation between

Indexed as

cancer stem cellsEIPANa+/H+ exchanger 7non-small cell lung cancerPD-L1STAT3

Identifiers

PMID37970357
PMCPMC10636675
OpenAlexW4388737079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.